Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resection

Anesthesia and Analgesia

Volumn 102, Issue 5, 2006, Pages 1556-1558

  Moore II, Thomas A ^a,b   Markert, James M ^a   Knowlton, Robert C ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUPIVACAINE; DEXMEDETOMIDINE; FENTANYL; LIDOCAINE; MIDAZOLAM; PROPOFOL; REMIFENTANIL; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN MAPPING; CANCER SURGERY; CASE REPORT; CRANIOTOMY; FEMALE; GENERAL ANESTHESIA; GLIOBLASTOMA; HUMAN; INTENSIVE CARE; PRIORITY JOURNAL; SEDATION; WAKEFULNESS;

EID: 33646203653     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000200286.15825.6c     Document Type: Article

References (14)

1. Matz PG, Cobbs C, Berger MS. Intraoperative cortical mapping as a guide to the surgical resection of gliomas. J Neuro Oncol 1999;42:233-45.
2. Manninen P, Contreras J. Anesthetic considerations for craniotomy in awake patients. Int Anesthesiol Clin 1986;24:157-74.
3. Johnson KB, Egan TD. Remifentanil and propofol combination for awake craniotomy: case report with pharmacokinetic simulations. J Neurosurg Anesthesiol 1998;10:25-9.
4. Hans P, Bonhomme V, Born JD, et al. Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy. Anaesthesia 2000;55:255-9.
5. Bekker AY, Kaufman B, Samir H. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 2001;92:1251-3.
6. Bustillo MA, Lazar RM, Finck AD, et al. Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: a retrospective case report series. J Neurosurg Anesthesiol 2002;14:209-12.
7. Mack PF, Perrine K, Kobylarz G, et al. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurgical Anesthesiol 2004;16:20-5.
8. Salonen M, Reid K, Maze M. Synergistic interaction between α2-adrenergic agonists and benzodiazepines in rats. Anesthesiology 1992;76:1004-11.
9. Khan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999;83:372-80.
10. Ebert TJ, Hall JE, Barney JA, Uhrich TB. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94.
11. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705.
12. Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (G187084B) and its major metabolite (G19029) in patients undergoing elective inpatient surgery. Anesthesiology 1993;79:893-903.
13. White PF, Smith I. Propofol. In: White PF, ed. Intravenous anesthesia. Baltimore: Williams and Wilkins, 1997;111-52.
14. Reeves JG, Glass SA, Lubarsky DA. Intravenous nonopioid anesthetics. In: Miller RD, ed. Miller's Anesthesia, 6th ed. Philadelphia: Elsevier Churchill Livingstone, 2005;317-78.